Roivant Sciences Ltd (ROIV)

11.84 -0.04 (-0.34%) USD  |  NASDAQ  |  Dec 13, 16:00
11.72 -0.12 (-1.01%) After-Hours: 20:00
More

Roivant Sciences EV to CFO

EV to CFO Chart

View EV to CFO for ROIV.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cumulative Total Returns Versus Peers
Start Trial

Historical Data

View Historical Data
Start Trial

EV to CFO Range, Past 5 Years

View EV to CFO Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EV to CFO Benchmarks

View EV to CFO Benchmarks
Start Trial
Organon & Co Upgrade
AstraZeneca PLC Upgrade
Adaptimmune Therapeutics PLC Upgrade
Biodexa Pharmaceuticals PLC --
Verona Pharma PLC Upgrade

EV to CFO Related Metrics

EV to EBITDA Upgrade
EV to EBIT Upgrade
EV to Revenues Upgrade
EV to Free Cash Flow Upgrade
EV to Assets (Quarterly) Upgrade
EV to Earnings Upgrade